Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2023-03-21 Annual Report
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 13th fiscal year (2022) of Genesystem Co., Ltd. It contains comprehensive financial, operational, and governance information, including a table of contents, management discussion, and financial statements. This is a standard annual filing required by the Financial Supervisory Service (FSS) in South Korea, which corresponds to the 10-K category in the provided schema. FY 2022
2023-03-21 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GeneSystem. It contains the agenda for the 13th Annual General Meeting, including items such as the approval of financial statements, board activities, and management reports. This document is a formal proxy statement/notice sent to shareholders to inform them of the meeting and solicit their participation/votes. In the context of the provided categories, this fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'GeneSystem'. It outlines the date, location, and the agenda items (resolutions) to be voted upon, such as the approval of financial statements, election of directors, and amendments to the articles of incorporation. This type of document is a standard proxy solicitation material sent to shareholders to inform them of an upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (GeneSystem) announcing a significant change in financial performance (revenue and profit/loss structure) exceeding 30%. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides key financial highlights and reasons for the variance, fitting the definition of an Earnings Release (ER) as it is an initial announcement of financial results before the final audited report. FY 2022
2023-02-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific executive (Hong Sa-cheol) of the company 'Genesystem'. This type of filing is a standard regulatory requirement for insider trading/ownership reporting, which corresponds to the 'Director's Dealing' category.
2022-12-15 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (the 13th Annual General Meeting). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the record date for shareholder rights. Given its nature as a regulatory notification regarding meeting logistics, it falls under the general regulatory filing category.
2022-12-15 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.